Drug class · Oncology & immunology
Kinase inhibitors Drug Codes & NDCs
Small-molecule drugs that inhibit one or more protein kinases. Most are oral products dispensed by pharmacies.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Gavretopralsetinib | Pralsetinib 100 mg/1 | CapsuleOral | Rigel Pharmaceuticals, Inc. | 71332-006 |
| Gefitinib | Gefitinib 250 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals, Inc. | 0480-4053 |
| Gefitinib | Gefitinib 250 mg/1 | Tablet, CoatedOral | Ingenus Pharmaceuticals, LLC | 50742-366 |
| Gefitinib | Gefitinib 250 mg/1 | Tablet, CoatedOral | Qilu Pharmaceutical Co., Ltd. | 67184-0531 |
| Gefitinib | Gefitinib 250 mg/1 | Tablet, Film coatedOral | Natco Pharma USA LLC | 69339-168 |
| Gilotrifafatinib | Afatinib 30 mg/1 | Tablet, Film coatedOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0137 |
| Gilotrifafatinib | Afatinib 40 mg/1 | Tablet, Film coatedOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0138 |
| Gilotrifafatinib | Afatinib 20 mg/1 | Tablet, Film coatedOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0141 |
| Gleevecimatinib mesylate | Imatinib mesylate 100 mg/1 | TabletOral | Novartis Pharmaceuticals Corporation | 0078-0401 |
| Gleevecimatinib mesylate | Imatinib mesylate 400 mg/1 | TabletOral | Novartis Pharmaceuticals Corporation | 0078-0649 |
| Gleevecimatinib mesylate | Imatinib mesylate 400 mg/1 | TabletOral | Novartis Pharmaceuticals Corporation | 0078-1490 |
| Gomeklimirdametinib | Mirdametinib 1 mg/1 | CapsuleOral | SpringWorks Therapeutics, Inc. | 82448-130 |
| Gomeklimirdametinib | Mirdametinib 1 mg/1 | Tablet, For suspensionOral | SpringWorks Therapeutics, Inc. | 82448-134 |
| Gomeklimirdametinib | Mirdametinib 2 mg/1 | CapsuleOral | SpringWorks Therapeutics, Inc. | 82448-260 |
| Hernexeoszongertinib | Zongertinib 60 mg/1 | Tablet, Film coatedOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-9257 |
| Hyftorsirolimus | Sirolimus 2 mg/g | GelTopical | Nobelpharma America, LLC | 73683-101 |
| Ibrancepalbociclib | Palbociclib 75 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-0187 |
| Ibrancepalbociclib | Palbociclib 100 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-0188 |
| Ibrancepalbociclib | Palbociclib 125 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-0189 |
| Ibrancepalbociclib | Palbociclib 75 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0284 |
| Ibrancepalbociclib | Palbociclib 100 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0486 |
| Ibrancepalbociclib | Palbociclib 125 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0688 |
| Ibrancepalbociclib | Palbociclib 75 mg/1 | Tablet, Film coatedOral | U.S. Pharmaceuticals | 63539-284 |
| Ibrancepalbociclib | Palbociclib 100 mg/1 | Tablet, Film coatedOral | U.S. Pharmaceuticals | 63539-486 |
| Ibrancepalbociclib | Palbociclib 125 mg/1 | Tablet, Film coatedOral | U.S. Pharmaceuticals | 63539-688 |